Drug Discovery Outsourcing Market to Reach $16.93 Billion by 2034 as AI Tools Accelerate Adoption
Updated
Updated · Fortune Business Insights · Jun 25
Drug Discovery Outsourcing Market to Reach $16.93 Billion by 2034 as AI Tools Accelerate Adoption
1 articles · Updated · Fortune Business Insights · Jun 25
Summary
$16.93 billion is the projected size of the global drug discovery outsourcing market by 2034, up from $8.08 billion in 2025 and $8.75 billion expected in 2026, implying an 8.6% CAGR.
Chronic disease demand, more complex discovery programs and broader outsourcing by pharma and biotech companies are driving growth, while CROs are adding AI, machine learning and computational platforms to cut timelines and late-stage failure risk.
Chemistry services led the market in 2025, lead optimization held a 30.2% share, and small molecules accounted for 68.9%, reflecting strong demand for outsourced early-stage work in conventional drug development.
North America remained the largest region with a $3.02 billion market in 2025, while India, Brazil and other emerging markets offer expansion opportunities despite limits from weak CRO capacity, data security and IP protection concerns.